Enteral formulations for treatment of inflammation and infection
US5397778A · kind A · utility
27Cited by
34References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 15, 1994 |
| Grant date | Mar 14, 1995 |
| Priority date | — |
| Expiry date | Apr 15, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S426/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention features saponin containing enteral formulations for treatment of infection and inflammation. These saponin containing formulations are particularly useful in conjunction with oils rich in .omega.3 polyunsaturated fatty acids such as fish oils and flax oil but also show benefits with .omega.6 rich oils such as borage oil, black currant seed oil, canola oil and rapeseed oil. These formulations may also contain a lignan from the sesamin family.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.